2016
DOI: 10.1016/j.prp.2016.06.004
|View full text |Cite
|
Sign up to set email alerts
|

The synergistic effect between vanillin and doxorubicin in ehrlich ascites carcinoma solid tumor and MCF-7 human breast cancer cell line

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
39
0
4

Year Published

2017
2017
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 50 publications
(45 citation statements)
references
References 30 publications
2
39
0
4
Order By: Relevance
“…Meanwhile, pre-treatment with vanillin in this study reduced gastric levels of TBARs and increased GSH level, SOD and CAT activities indicating a decrement in the indomethacin induced oxidative stress and this was superior to ranitidine pre-treatment. These findings are in harmony with earlier reports who noted the antioxidant property of vanillin [20][21][22][23].…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…Meanwhile, pre-treatment with vanillin in this study reduced gastric levels of TBARs and increased GSH level, SOD and CAT activities indicating a decrement in the indomethacin induced oxidative stress and this was superior to ranitidine pre-treatment. These findings are in harmony with earlier reports who noted the antioxidant property of vanillin [20][21][22][23].…”
Section: Discussionsupporting
confidence: 92%
“…Previous studies also noted vanillin's anti-inflammatory property [16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32]. Moreover it was proved that also vanillic acid regulated ulcerative colitis via inhibition NF-κB p65 activation and reduction in pro-inflammatory cytokines production; IL-1, IL-6 and TNF-α [33].…”
Section: Discussionmentioning
confidence: 94%
“…[ 18,13,19 ] We reported antineoplastic activity of vanillin in vivo in mouse model of breast cancer and in MCF‐7 human breast cancer cell line. [ 20 ] Vanillin exerted antineoplastic effect similar to that of doxorubicin with improved survival and no side effects as seen in doxorubicin treatment. The combination of doxorubicin and vanillin significantly inhibited tumour growth in vivo and in MCF‐7 human breast cancer cell line more than any single drug.…”
Section: Introductionmentioning
confidence: 99%
“…The administration of 150 mg/kg/day F2 in mice significantly reduced tumor volume and tumor weight. Synergism between vanillin and doxorubicin showed similar results in Ehrlich solid tumors ( Elsherbiny et al, 2016 ). In vitro , F2 induced oxidative stress in cancer cells, resulting in intense lipoperoxidation.…”
Section: Discussionmentioning
confidence: 80%